Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4

References

• Tawil R, van der Maarel SM, Tapscott SJ. Facioscapulohumeral dystrophy: the path to consensus on pathophysiology. Skelet Muscle 2014; 4:12; PMID:24940479; http://dx.doi.org/10.1186/2044-5040-4-12
   PubMed Web of Science ®Google Scholar
• Deenen JC, Arnts H, van der Maarel SM, Padberg GW, Verschuuren JJ, Bakker E, Weinreich SS, Verbeek AL, van Engelen BG. Population-based incidence and prevalence of facioscapulohumeral dystrophy. Neurology 2014; 83:1056–9; PMID:25122204; http://dx.doi.org/10.1212/WNL.0000000000000797
   PubMed Web of Science ®Google Scholar
• Gabriels J, Beckers MC, Ding H, De Vriese A, Plaisance S, van der Maarel SM, Padberg GW, Frants RR, Hewitt JE, Collen D, et al. Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene 1999; 236:25–32; PMID:10433963; http://dx.doi.org/10.1016/S0378-1119(99)00267-X
   PubMed Web of Science ®Google Scholar
• Wijmenga C, Frants RR, Brouwer OF, Moerer P, Weber JL, Padberg GW. Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet 1990; 336:651–3; PMID:1975852; http://dx.doi.org/10.1016/0140-6736(90)92148-B
   PubMed Web of Science ®Google Scholar
• Wijmenga C, Hewitt JE, Sandkuijl LA, Clark LN, Wright TJ, Dauwerse HG, Gruter AM, Hofker MH, Moerer P, Williamson R, et al. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet 1992; 2:26–30; PMID:1363881; http://dx.doi.org/10.1038/ng0992-26
   PubMed Web of Science ®Google Scholar
• van der Maarel SM, Tawil R, Tapscott SJ. Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence. Trends Mol Med 2011; 17:252–8; PMID:21288772; http://dx.doi.org/10.1016/j.molmed.2011.01.001
   PubMed Web of Science ®Google Scholar
• Lemmers RJ, van der Vliet PJ, Klooster R, Sacconi S, Camano P, Dauwerse JG, Snider L, Straasheijm KR, van Ommen GJ, Padberg GW, et al. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 2010; 329:1650–3; PMID:20724583; http://dx.doi.org/10.1126/science.1189044
   PubMed Web of Science ®Google Scholar
• Snider L, Geng LN, Lemmers RJ, Kyba M, Ware CB, Nelson AM, Tawil R, Filippova GN, van der Maarel SM, Tapscott SJ, et al. Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. PLoS Genet 2010; 6:e1001181; PMID:21060811; http://dx.doi.org/10.1371/journal.pgen.1001181
   PubMed Web of Science ®Google Scholar
• Geng LN, Yao Z, Snider L, Fong AP, Cech JN, Young JM, van der Maarel SM, Ruzzo WL, Gentleman RC, Tawil R, et al. DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. Dev Cell 2012; 22:38–51; PMID:22209328; http://dx.doi.org/10.1016/j.devcel.2011.11.013
   PubMed Web of Science ®Google Scholar
• Kowaljow V, Marcowycz A, Ansseau E, Conde CB, Sauvage S, Matteotti C, Arias C, Corona ED, Nunez NG, Leo O, et al. The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscul Disord 2007; 17:611–23; PMID:17588759; http://dx.doi.org/10.1016/j.nmd.2007.04.002
   PubMed Web of Science ®Google Scholar
• Wallace LM, Garwick SE, Mei W, Belayew A, Coppee F, Ladner KJ, Guttridge D, Yang J, Harper SQ. DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann Neurol 2011; 69:540–52; PMID:21446026; http://dx.doi.org/10.1002/ana.22275
   PubMed Web of Science ®Google Scholar
• Gilbert JR, Stajich JM, Wall S, Carter SC, Qiu H, Vance JM, Stewart CS, Speer MC, Pufky J, Yamaoka LH, et al. Evidence for heterogeneity in facioscapulohumeral muscular dystrophy (FSHD). Am J Hum Genet 1993; 53:401–8; PMID:8328457
   PubMed Web of Science ®Google Scholar
• van Deutekom JC, Wijmenga C, van Tienhoven EA, Gruter AM, Hewitt JE, Padberg GW, van Ommen GJ, Hofker MH, Frants RR. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum Mol Genet 1993; 2:2037–42; PMID:8111371; http://dx.doi.org/10.1093/hmg/2.12.2037
   PubMed Web of Science ®Google Scholar
• Lemmers RJ, Tawil R, Petek LM, Balog J, Block GJ, Santen GW, Amell AM, van der Vliet PJ, Almomani R, Straasheijm KR, et al. Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet 2012; 44:1370–4; PMID:23143600; http://dx.doi.org/10.1038/ng.2454
   PubMed Web of Science ®Google Scholar
• Sacconi S, Lemmers RJ, Balog J, van der Vliet PJ, Lahaut P, van Nieuwenhuizen MP, Straasheijm KR, Debipersad RD, Vos-Versteeg M, Salviati L, et al. The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1. Am J Hum Genet 2013; 93:744–51; PMID:24075187; http://dx.doi.org/10.1016/j.ajhg.2013.08.004
   PubMed Web of Science ®Google Scholar
• Lemmers RJ, van den Boogaard ML, van der Vliet PJ, Donlin-Smith CM, Nations SP, Ruivenkamp CA, Heard P, Bakker B, Tapscott S, Cody JD, et al. Hemizygosity for SMCHD1 in Facioscapulohumeral Muscular Dystrophy Type 2: Consequences for 18p Deletion Syndrome. Hum Mutat 2015; 36:679–83; PMID:25820463; http://dx.doi.org/10.1002/humu.22792
   PubMed Web of Science ®Google Scholar
• Bodega B, Ramirez GD, Grasser F, Cheli S, Brunelli S, Mora M, Meneveri R, Marozzi A, Mueller S, Battaglioli E, et al. Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation. BMC Biol 2009; 7:41; PMID:19607661; http://dx.doi.org/10.1186/1741-7007-7-41
   PubMed Web of Science ®Google Scholar
• Zeng W, de Greef JC, Chen YY, Chien R, Kong X, Gregson HC, Winokur ST, Pyle A, Robertson KD, Schmiesing JA, et al. Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD). PLoS Genet 2009; 5:e1000559; PMID:19593370; http://dx.doi.org/10.1371/journal.pgen.1000559
   PubMed Web of Science ®Google Scholar
• Balog J, Thijssen PE, de Greef JC, Shah B, van Engelen BG, Yokomori K, Tapscott SJ, Tawil R, van der Maarel SM. Correlation analysis of clinical parameters with epigenetic modifications in the DUX4 promoter in FSHD. Epigenetics 2012; 7:579–84; PMID:22522912; http://dx.doi.org/10.4161/epi.20001
   PubMed Web of Science ®Google Scholar
• de Greef JC, Lemmers RJ, van Engelen BG, Sacconi S, Venance SL, Frants RR, Tawil R, van der Maarel SM. Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHD. Hum Mutat 2009; 30:1449–59; PMID:19728363; http://dx.doi.org/10.1002/humu.21091
   PubMed Web of Science ®Google Scholar
• Hartweck LM, Anderson LJ, Lemmers RJ, Dandapat A, Toso EA, Dalton JC, Tawil R, Day JW, van der Maarel SM, Kyba M. A focal domain of extreme demethylation within D4Z4 in FSHD2. Neurology 2013; 80:392–9; PMID:23284062; http://dx.doi.org/10.1212/WNL.0b013e31827f075c
   PubMed Web of Science ®Google Scholar
• van Overveld PG, Lemmers RJ, Sandkuijl LA, Enthoven L, Winokur ST, Bakels F, Padberg GW, van Ommen GJ, Frants RR, van der Maarel SM. Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat Genet 2003; 35:315–7; PMID:14634647; http://dx.doi.org/10.1038/ng1262
   PubMed Web of Science ®Google Scholar
• Cabianca DS, Casa V, Bodega B, Xynos A, Ginelli E, Tanaka Y, Gabellini D. A long ncRNA links copy number variation to a polycomb/trithorax epigenetic switch in FSHD muscular dystrophy. Cell 2012; 149:819–31; PMID:22541069; http://dx.doi.org/10.1016/j.cell.2012.03.035
   PubMed Web of Science ®Google Scholar
• Cabianca DS, Casa V, Gabellini D. A novel molecular mechanism in human genetic disease: a DNA repeat-derived lncRNA. RNA Biol 2012; 9:1211–7; PMID:23047063; http://dx.doi.org/10.4161/rna.21922
   PubMed Web of Science ®Google Scholar
• Snider L, Asawachaicharn A, Tyler AE, Geng LN, Petek LM, Maves L, Miller DG, Lemmers RJ, Winokur ST, Tawil R, et al. RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy. Hum Mol Genet 2009; 18:2414–30; PMID:19359275; http://dx.doi.org/10.1093/hmg/ddp180
   PubMed Web of Science ®Google Scholar
• Lim JW, Snider L, Yao Z, Tawil R, Van Der Maarel SM, Rigo F, Bennett CF, Filippova GN, Tapscott SJ. DICER/AGO-dependent epigenetic silencing of D4Z4 repeats enhanced by exogenous siRNA suggests mechanisms and therapies for FSHD. Hum Mol Genet 2015; 24(17):4817–28; PMID:26041815; http://dx.doi.org/10.1093/hmg/ddv206
   PubMed Web of Science ®Google Scholar
• Jones TI, Chen JC, Rahimov F, Homma S, Arashiro P, Beermann ML, King OD, Miller JB, Kunkel LM, Emerson CP, Jr., et al. Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis. Hum Mol Genet 2012; 21:4419–30; PMID:22798623; http://dx.doi.org/10.1093/hmg/dds284
   PubMed Web of Science ®Google Scholar
• Krom YD, Dumonceaux J, Mamchaoui K, den Hamer B, Mariot V, Negroni E, Geng LN, Martin N, Tawil R, Tapscott SJ, et al. Generation of isogenic D4Z4 contracted and noncontracted immortal muscle cell clones from a mosaic patient: a cellular model for FSHD. Am J Pathol 2012; 181:1387–401; PMID:22871573; http://dx.doi.org/10.1016/j.ajpath.2012.07.007
   PubMed Web of Science ®Google Scholar
• Tassin A, Laoudj-Chenivesse D, Vanderplanck C, Barro M, Charron S, Ansseau E, Chen YW, Mercier J, Coppee F, Belayew A. DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy? J Cell Mol Med 2013; 17:76–89; PMID:23206257; http://dx.doi.org/10.1111/j.1582-4934.2012.01647.x
   PubMed Web of Science ®Google Scholar
• Asp P, Blum R, Vethantham V, Parisi F, Micsinai M, Cheng J, Bowman C, Kluger Y, Dynlacht BD. Genome-wide remodeling of the epigenetic landscape during myogenic differentiation. Proc Natl Acad Sci U S A 2011; 108:E149–58; PMID:21551099; http://dx.doi.org/10.1073/pnas.1102223108
   PubMed Web of Science ®Google Scholar
• Nozawa RS, Nagao K, Igami KT, Shibata S, Shirai N, Nozaki N, Sado T, Kimura H, Obuse C. Human inactive X chromosome is compacted through a PRC2-independent SMCHD1-HBiX1 pathway. Nat Struct Mol Biol 2013; 20:566–73; PMID:23542155; http://dx.doi.org/10.1038/nsmb.2532
   PubMed Web of Science ®Google Scholar
• McCabe MT, Ott HM, Ganji G, Korenchuk S, Thompson C, Van Aller GS, Liu Y, Graves AP, Della Pietra A, 3rd, Diaz E, et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 2012; 492:108–12; PMID:23051747; http://dx.doi.org/10.1038/nature11606
   PubMed Web of Science ®Google Scholar
• Reddington JP, Perricone SM, Nestor CE, Reichmann J, Youngson NA, Suzuki M, Reinhardt D, Dunican DS, Prendergast JG, Mjoseng H, et al. Redistribution of H3K27me3 upon DNA hypomethylation results in de-repression of Polycomb target genes. Genome Biol 2013; 14:R25; PMID:23531360; http://dx.doi.org/10.1186/gb-2013-14-3-r25
   PubMed Web of Science ®Google Scholar
• Juan AH, Kumar RM, Marx JG, Young RA, Sartorelli V. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell 2009; 36:61–74; PMID:19818710; http://dx.doi.org/10.1016/j.molcel.2009.08.008
   PubMed Web of Science ®Google Scholar
• Zeng W, Chen YY, Newkirk DA, Wu B, Balog J, Kong X, Ball AR, Jr., Zanotti S, Tawil R, Hashimoto N, et al. Genetic and epigenetic characteristics of FSHD-associated 4q and 10q D4Z4 that are distinct from non-4q/10q D4Z4 homologs. Hum Mutat 2014; 35:998–1010; PMID:24838473; http://dx.doi.org/10.1002/humu.22593
   PubMed Web of Science ®Google Scholar
• Simon JA, Kingston RE. Mechanisms of polycomb gene silencing: knowns and unknowns. Nat Rev Mol Cell Biol 2009; 10:697–708; PMID:19738629; http://dx.doi.org/10.1038/nrn2731
   PubMed Web of Science ®Google Scholar
• Cherblanc FL, Chapman KL, Brown R, Fuchter MJ. Chaetocin is a nonspecific inhibitor of histone lysine methyltransferases. Nat Chem Biol 2013; 9:136–7; PMID:23416387; http://dx.doi.org/10.1038/nchembio.1187
   PubMed Web of Science ®Google Scholar
• Stadler G, Rahimov F, King OD, Chen JC, Robin JD, Wagner KR, Shay JW, Emerson CP, Jr., Wright WE. Telomere position effect regulates DUX4 in human facioscapulohumeral muscular dystrophy. Nat Struct Mol Biol 2013; 20:671–8; PMID:23644600; http://dx.doi.org/10.1038/nsmb.2571
   PubMed Web of Science ®Google Scholar
• Grolimund L, Aeby E, Hamelin R, Armand F, Chiappe D, Moniatte M, Lingner J. A quantitative telomeric chromatin isolation protocol identifies different telomeric states. Nat Commun 2013; 4:2848; PMID:24270157; http://dx.doi.org/10.1038/ncomms3848
   PubMed Web of Science ®Google Scholar
• Yao Z, Fong AP, Cao Y, Ruzzo WL, Gentleman RC, Tapscott SJ. Comparison of endogenous and overexpressed MyoD shows enhanced binding of physiologically bound sites. Skelet Muscle 2013; 3:8; PMID:23566431; http://dx.doi.org/10.1186/2044-5040-3-8
   PubMed Web of Science ®Google Scholar